News

FDA expands recall on blood pressure drug valsartan due to probable carcinogen 02:42. Online pharmacy Valisure has discovered another cancer-causing chemical in blood-pressure pills made by ...
Aurobindo Pharma USA, Inc. is voluntarily recalling valsartan tablets that might include N-nitrosodiethylamine (NDEA), a possible human carcinogen.
Valsartan and Hydrochlorothiazide Tablets USP, 80/12.5 mg, 160/12.5 mg, 160/25 mg, 320/12.5 mg and 320/25 mg, had U.S. sales of approximately$1.6 billion for the 12 months ending June 30, 2012 ...
Dexa Medica is one of Indonesia's largest ethical pharmaceutical companies and a prominent player in the domestic pharmaceutical market. PAS-X will be integrated with ERP, LIMS, DMS, LDAP and IPC ...
T. he Business Competition Supervisory Agency (KPPU) fined pharmaceutical companies PT Pfizer Indonesia and PT Dexa Medica Rp 25 billion (US$2.8 million) and Rp 20 billion respectively on Monday ...
“I am confident that Dexa Medica will continue to improve the delivery of quality health care for consumers in the months ahead. Related News. Margaret, 39 seeks N10m for breast cancer treatment; ...
And speaking after the verdict, Dexa Medica spokesperson Rikrik Rizkiyanan said the decision was “unfair because the verdict was taken without considering ‘apple to apple’ price comparisons”, reports ...